Brief: Orgenesis Reports Q1 Revenue Of $9.4 Million
07/05/2021 12:07
May 7 (Reuters) - Orgenesis Inc ORGS.O :
* ORGENESIS FIRST QUARTER 2021 REVENUE INCREASES 400% TO
$9.4
MILLION REFLECTING INITIAL SUCCESS OF POCARE PLATFORM
* ORGENESIS INC QTRLY TOTAL REVENUE $9.4 MILLION VERSUS $1.9
MILLION
* ORGENESIS INC - CASH AND CASH EQUIVALENTS OF $41.8 MILLION
AS OF
MARCH 31, 2021
Source text for Eikon: ID:nGNX7ypM2h
Further company coverage: ORGS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orgenesis
See all newsBrief: Orgenesis Nasdaq To Delist Co'S Common Stock, Securities Trading Will Be Suspended On Oct 21
Brief: Orgenesis Announces Positive Results From A Real-World Study Of Org-101 Car-T Therapy
Brief: Orgenesis Announces Strategic Partnership With Harley Street Healthcare Group
Brief: Orgenesis Says Entered Purchase Deal With Theracell For Purchase Of 50% Outstanding Ownership Rights & Equity Interests In Theracell Laboratories Ike
Brief: Orgenesis Received Nasdaq Hearings Panel Decision Which Granted Company Until October 14 To Regain Compliance With Bid Price And Equity Rules